跳至主要内容
临床试验/ACTRN12616001334493
ACTRN12616001334493尚未招募未知

An assessment of the role of Faecal Microbiota Transplant (FMT) in the treatment of obesity and type 2 diabetes.

Dr Stephen Fairley0 个研究点目标入组 34 人开始时间: 2016年9月26日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
34

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 65 Years(—)
性别
All

入选标准

  • Aged 18-65 years, able to understand the plain language summary and competent to make informed consent.
  • Obese (BMI >= 30), features of MetS (central obesity plus at least one of diabetes, HbA1c >6.5% or 48 mmol/mol, hypertension (BP>140/90), dyslipidemia (TG>1.5 mmol/L and/or HDL-Cholesterol <1.0 mmol/l).

排除标准

  • People having,
  • a) major mental or other illnesses which would preclude consent or affect clinical risk (e.g. cancer diagnosis, known gut polyps).
  • b) currently taking medication which would affect gut flora (e.g. antibiotics).
  • c) Pregnant women

研究者

发起方
Dr Stephen Fairley

相似试验